EVALUATION OF IN SILICO-DESIGNED MUTP53 ANTI-MISFOLDING SMALL MOLECULES IN LUNG CANCER

$489,738FY2025Defense Health AgencyDOD

Treventis Corporation

Investigators

View source on USAspending →